Hans E. Purkey

3.1k total citations
28 papers, 1.3k citations indexed

About

Hans E. Purkey is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hans E. Purkey has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Hans E. Purkey's work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Alzheimer's disease research and treatments (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Hans E. Purkey is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Alzheimer's disease research and treatments (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Hans E. Purkey collaborates with scholars based in United States, United Kingdom and China. Hans E. Purkey's co-authors include Jeffery W. Kelly, James C. Sacchettini, S.K. Palaninathan, H. Michael Petrassi, Kyle P. Chiang, Evan T. Powers, Michael I. Dorrell, Nilofar N. Mohamedmohaideen, Hossein Razavi and Thomas Klabunde and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Hans E. Purkey

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans E. Purkey United States	17	806	313	263	237	189	28	1.3k
Chidambaram Ramachandran Canada	29	1.9k 2.3×	251 0.8×	203 0.8×	306 1.3×	175 0.9×	55	2.5k
Charles B. Glaser United States	19	676 0.8×	142 0.5×	457 1.7×	106 0.4×	142 0.8×	35	1.6k
F. Javier Piedrafita United States	19	950 1.2×	205 0.7×	139 0.5×	158 0.7×	28 0.1×	42	1.5k
Alan Hruza United States	15	650 0.8×	212 0.7×	266 1.0×	190 0.8×	131 0.7×	23	1.2k
Thu H. Truong United States	15	743 0.9×	139 0.4×	105 0.4×	251 1.1×	77 0.4×	24	1.2k
Lidia Ciccone Italy	18	484 0.6×	117 0.4×	178 0.7×	160 0.7×	90 0.5×	56	808
Thomas W von Geldern United States	26	617 0.8×	853 2.7×	458 1.7×	177 0.7×	33 0.2×	57	2.1k
G. Pochetti Italy	26	1.2k 1.5×	408 1.3×	158 0.6×	285 1.2×	31 0.2×	73	1.7k
K Ruckpaul Germany	22	805 1.0×	52 0.2×	139 0.5×	282 1.2×	281 1.5×	116	1.5k
Aubry K. Miller Germany	23	817 1.0×	580 1.9×	82 0.3×	203 0.9×	52 0.3×	55	1.7k

Countries citing papers authored by Hans E. Purkey

Since Specialization

Citations

This map shows the geographic impact of Hans E. Purkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans E. Purkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans E. Purkey more than expected).

Fields of papers citing papers by Hans E. Purkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans E. Purkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans E. Purkey. The network helps show where Hans E. Purkey may publish in the future.

Co-authorship network of co-authors of Hans E. Purkey

This figure shows the co-authorship network connecting the top 25 collaborators of Hans E. Purkey. A scholar is included among the top collaborators of Hans E. Purkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans E. Purkey. Hans E. Purkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Julián, Cristina, Navdeep Pal, Anda Gershon, et al.. (2023). Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC Cancer. 23(1). 352–352. 10 indexed citations

Chan, Emily, Carl Ng, Junko Aimi, et al.. (2022). Assessment of KRAS G12C Target Engagement by a Covalent Inhibitor in Tumor Biopsies Using an Ultra-Sensitive Immunoaffinity 2D-LC–MS/MS Approach. Analytical Chemistry. 94(37). 12927–12933. 7 indexed citations

Julián, Cristina, Navdeep Pal, Anda Gershon, et al.. (2021). Abstract 660: Real-world prevalence of metastasis and overall survival (OS) in patients with advanced non-small cell lung cancer (aNSCLC) with KRAS G12C and with or without STK11 or KEAP1 mutations. Cancer Research. 81(13_Supplement). 660–660. 1 indexed citations

Hanan, Emily J., Marian C. Bryan, Yuan Chen, et al.. (2015). 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 26(2). 534–539. 39 indexed citations

Volgraf, Matthew, Lina Chan, Malcolm P. Huestis, et al.. (2014). Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(11). 2477–2480. 9 indexed citations

Fauber, Benjamin P., Peter S. Dragovich, Jinhua Chen, et al.. (2014). Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 24(24). 5683–5687. 17 indexed citations

O’Brien, Thomas, Hans E. Purkey, A. Hitz, et al.. (2014). Abstract 964: Inhibiting glycolysis with an LDHA inhibitor: A new solution to an old problem. Cancer Research. 74(19_Supplement). 964–964. 2 indexed citations

Long, Daniel D., Bryan A. Frieman, Sharath S. Hegde, et al.. (2012). A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters. 23(4). 939–943. 15 indexed citations

Ameriks, Michael K., Scott D. Bembenek, Matthew Burdett, et al.. (2010). Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4060–4064. 16 indexed citations

10.

Hanan, Emily J., Raymond V. Fucini, M.J. Romanowski, et al.. (2008). Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5186–5189. 22 indexed citations

11.

Fucini, Raymond V., Emily J. Hanan, M.J. Romanowski, et al.. (2008). Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5648–5652. 30 indexed citations

12.

O’Brien, Thomas, Bruce J. Fahr, Joni W. Lam, et al.. (2005). Structural analysis of caspase-1 inhibitors derived from Tethering. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(5). 451–458. 16 indexed citations

13.

Fahr, Bruce J., Thomas O’Brien, Nathan D. Waal, et al.. (2005). Tethering identifies fragment that yields potent inhibitors of human caspase-1. Bioorganic & Medicinal Chemistry Letters. 16(3). 559–562. 19 indexed citations

14.

Razavi, Hossein, Evan T. Powers, Hans E. Purkey, et al.. (2005). Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(4). 1075–1078. 42 indexed citations

15.

Purkey, Hans E., S.K. Palaninathan, Kathleen C. Kent, et al.. (2004). Hydroxylated Polychlorinated Biphenyls Selectively Bind Transthyretin in Blood and Inhibit Amyloidogenesis: Rationalizing Rodent PCB Toxicity. Chemistry & Biology. 11(12). 1719–1728. 118 indexed citations

16.

Razavi, Hossein, S.K. Palaninathan, Evan T. Powers, et al.. (2003). Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action. Angewandte Chemie International Edition. 42(24). 2758–2761. 200 indexed citations

17.

McCammon, Margaret G., David J. Scott, Catherine A. Keetch, et al.. (2002). Screening Transthyretin Amyloid Fibril Inhibitors. Structure. 10(6). 851–863. 89 indexed citations

18.

Purkey, Hans E., Michael I. Dorrell, & Jeffery W. Kelly. (2001). Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma. Proceedings of the National Academy of Sciences. 98(10). 5566–5571. 101 indexed citations

19.

Oza, Vibha, H. Michael Petrassi, Hans E. Purkey, & Jeffery W. Kelly. (1999). Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(1). 1–6. 65 indexed citations

20.

Peterson, Scott, Thomas Klabunde, Hilal A. Lashuel, et al.. (1998). Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proceedings of the National Academy of Sciences. 95(22). 12956–12960. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact